Systematic review / meta-analysis / 2014
Circulating fatty acids showed no strong evidence of predicting prostate cancer risk.
An individual participant meta-analysis examined 14 circulating fatty acids among 5,098 case patients and 6,649 control patients across seven prospective studies over an average 5.1-year follow-up. Stearic acid showed an inverse relationship with total disease (OR Q5 vs Q1 = 0.88, 95% CI: 0.78 to 1.00, P trend = .043). Modest positive associations occurred for eicosapentaenoic acid (OR = 1.14, 95% CI: 1.01 to 1.29) and docosapentaenoic acid (OR = 1.16, 95% CI: 1.02 to 1.33), with between-study heterogeneity.
- Study type
- Individual participant meta-analysis
- Who was studied
- 5,098 case patients and 6,649 control patients across 7 prospective studies
- What was measured
- Prostate cancer risk
THE PAPER
Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies.
Crowe FL, Appleby PN, Travis RC, Barnett M, Brasky TM, Bueno-de-Mesquita HB, Chajes V, Chavarro JE, Chirlaque MD, English DR, Gibson RA, Giles GG, Goodman GE, Henning SM, Kaaks R, King IB, Kolonel LN, Kristal AR, Neuhouser ML, Park SY, Severi G, Siddiq A, Stampfer MJ, Stattin P, Tangen CM, Tjønneland A, Trichopoulos D, Tumino R, Wilkens LR, Key TJ, Allen NE, Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group. J Natl Cancer Inst, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.